The FDA also expanded Repatha’s use as monotherapy to include patients with homozygous familial hypercholesterolemia
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
Doxorubicin Hydrochloride Liposome Injection is indicated for the treatment of Ovarian Cancer, AIDS-Related Kaposi's Sarcoma, and Multiple Myeloma
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
Topiramate is indicated as a treatment of epilepsy and migraine
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
Niacin is indicated to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B and triglycerides (TG)
Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA modelsfeatured in two peer-reviewed articles
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region
Subscribe To Our Newsletter & Stay Updated
